文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

危重患者连续性肾脏替代治疗剂量与死亡率:基于边际结构模型的回顾性队列研究

CONTINUOUS KIDNEY REPLACEMENT THERAPY DOSAGE AND MORTALITY IN CRITICALLY ILL PATIENTS: A RETROSPECTIVE COHORT STUDY USING MARGINAL STRUCTURAL MODEL.
PubMed 文献 · Shock · 2024-08-12
一句话结论在MIMIC-IV的1329例CKRT患者中,传统Cox模型显示CKRT剂量<13 mL/kg/h与90天死亡率显著相关,但校正时间依赖变量后该关联消失。

该回顾性队列利用MIMIC-IV数据库纳入接受CKRT超过24小时的成年AKI患者1329例,90天死亡率为49.6%,中位年龄62岁(IQR 52-72)。按13和20 mL/kg/h两个CKRT剂量阈值分组,仅校正基线变量的传统Cox回归显示CKRT剂量<13 mL/kg/h者90天死亡率显著更高(HR 1.70,95%CI 1.16-2.49)。采用边际结构模型校正时间依赖变量后,13或20 mL/kg/h阈值下CKRT剂量与死亡率均无显著关联,5-40 mL/kg/h范围内亦无显著关联。作者认为经个体化调整后可能不存在不安全CKRT剂量的下限,但较低CKRT剂量初期与较高死亡率相关。

要点

  • 1329例CKRT超过24小时的成年患者中,90天死亡率为49.6%,中位年龄62岁(IQR 52-72)。
  • 仅校正基线变量的传统Cox模型:CKRT剂量<13 mL/kg/h者90天死亡率显著高于≥13 mL/kg/h者(HR 1.70,95%CI 1.16-2.49)。
  • 校正时间依赖变量后,13和20 mL/kg/h两个阈值下CKRT剂量与90天死亡率均无显著关联。
  • 5-40 mL/kg/h范围内,实际输送的CKRT剂量与90天死亡率无显著关联。
  • 治疗期间CKRT剂量变化频繁;剂量<20和<13 mL/kg/h的患者在CKRT最初几天剂量普遍偏低,之后实际输送剂量升高。

适用人群与场景

  • MIMIC-IV数据库中接受CKRT超过24小时的成年患者。

研究设计与关键结果

  • 回顾性队列研究,基于MIMIC-IV数据库纳入1329例接受CKRT超过24小时的成年患者,90天死亡率为49.6%,中位年龄62岁(IQR 52-72)。
  • 按CKRT剂量阈值13和20 mL/kg/h分组,治疗期间CKRT剂量变化频繁。
  • 仅校正基线变量的传统Cox回归:CKRT剂量<13 mL/kg/h者90天死亡率显著高于≥13 mL/kg/h者(HR 1.70,95%CI 1.16-2.49)。
  • 校正时间依赖变量后,13和20 mL/kg/h阈值下CKRT剂量与90天死亡率均无显著关联。
  • 5-40 mL/kg/h范围内,实际输送的CKRT剂量与90天死亡率无显著关联。
  • 剂量<20和<13 mL/kg/h的患者在CKRT最初几天剂量普遍偏低,之后实际输送的CKRT剂量升高。

证据类型、等级与局限

  • 证据类型:回顾性队列研究,使用边际结构模型分析MIMIC-IV数据库。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,研究方法会影响CKRT剂量与死亡率关联的判断;经个体化调整后,可能不存在不安全CKRT剂量的下限。
  • 作者指出,较低CKRT剂量在初期与较高死亡率相关,但校正时间依赖变量后该关联消失。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background : Continuous kidney replacement therapy (CKRT) is a crucial intervention for hemodynamically unstable patients with acute kidney injury (AKI). Despite the recommendations to offer a CKRT dose of 20 to 25 mL/kg/h, the optimal CKRT dose remains uncertain, especially whether low-dose CKRT is associated with poor outcomes. This study investigated the association between low CKRT dosage and 90-day mortality using a marginal structural model (MSM). Methods : Using the MIMIC-IV database, adult patients who received CKRT for more than 24 h were included. Data on time-fixed and time-dependent variables were collected. Patients were categorized based on CKRT dose thresholds of 13 and 20 mL/kg/h. Results : Among the 1,329 patients, the 90-day mortality rate was 49.6%. The median age of the patients was 62 years (IQR: 52-72). Changes in CKRT dosing during treatment were frequent. Patients with a reduced delivered CKRT dose (<20 and <13 mL/kg/h) generally exhibited low values during the initial days of CKRT, with an increase in the delivered CKRT dose. After adjusting only for baseline variables (traditional Cox regression model), patients receiving CKRT doses <13 mL/kg/h had significantly greater 90-day mortality (HR: 1.70, 95% CI 1.16-2.49) than those receiving CKRT doses ≥13 mL/kg/h. However, after adjusting for time-dependent variables, the CKRT dose was not significantly associated with mortality at either the 13 or 20 mL/kg/h threshold. Additionally, there were no significant associations between the delivered CKRT dose and 90-day mortality within the range of 5 to 40 mL/kg/h. Conclusion : This study highlights the impact of methodological approaches on the association between CKRT dose and mortality and that with personalized adjustments, there may not be a lower limit of the unsafe CKRT dose. However, lower CKRT doses were initially associated with higher mortality, and adjusting for time-dependent variables nullified this association.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Faria MLM, Libório AB. CONTINUOUS KIDNEY REPLACEMENT THERAPY DOSAGE AND MORTALITY IN CRITICALLY ILL PATIENTS: A RETROSPECTIVE COHORT STUDY USING MARGINAL STRUCTURAL MODEL. Shock. 2024. PMID: 39186779. doi:10.1097/SHK.0000000000002435

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。